Article Versions Notes

Mancini A, Simeoli R, Cristiani L, Cairoli S, Ciciriello F, Boni A, Alghisi F, Rossi C, Antonetti G, Vici CD, et al. Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients. Pharmaceuticals. 2025; 18(7):1028. https://doi.org/10.3390/ph18071028

Mancini, Alessandro, Raffaele Simeoli, Luca Cristiani, Sara Cairoli, Fabiana Ciciriello, Alessandra Boni, Federico Alghisi, Chiara Rossi, Giacomo Antonetti, Carlo Dionisi Vici, and et al. 2025. "Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients" Pharmaceuticals 18, no. 7: 1028. https://doi.org/10.3390/ph18071028

Mancini, A., Simeoli, R., Cristiani, L., Cairoli, S., Ciciriello, F., Boni, A., Alghisi, F., Rossi, C., Antonetti, G., Vici, C. D., Fiocchi, A. G., Cutrera, R., & Goffredo, B. M. (2025). Development and Validation of a New LC-MS/MS Method for Simultaneous Quantification of Ivacaftor, Tezacaftor and Elexacaftor Plasma Levels in Pediatric Cystic Fibrosis Patients. Pharmaceuticals, 18(7), 1028. https://doi.org/10.3390/ph18071028